Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC)

被引:0
|
作者
A. Barnadas
M. Algara
O. Cordoba
A. Casas
M. Gonzalez
M. Marzo
A. Montero
M. Muñoz
A. Ruiz
F. Santolaya
T. Fernandez
机构
[1] Hospital de la Santa Cruz y San Pablo,Department of Medical Oncology
[2] Parc de Salut Mar,Department of Radio
[3] Hospital de la Vall d’Hebrón,oncology
[4] Hospital Virgen del Rocío,Department of Gynecology and Obstetrics
[5] Montesa Healthcare Center,Department of Medical Oncology
[6] Servicio Madrileño de Salud,Department of Radio
[7] Catalonian Health Institute,oncology
[8] Hospital Universitario HM Sanchinarro,Department of Medical Oncology
[9] Hospital Clínic Barcelona,Department of Medical Oncology
[10] Instituto Valenciano de Oncología,Department of Cardiology
[11] Ciudad San Pablo Healthcare Center,undefined
[12] Servicio Madrileño de Salud,undefined
[13] Hospital La Paz Madrid,undefined
来源
Clinical and Translational Oncology | 2018年 / 20卷
关键词
Breast cancer; Treatment chronic side effects sequelae; Follow-up guidelines; Primary care; Specialized care;
D O I
暂无
中图分类号
学科分类号
摘要
The increased incidence and decreased mortality of breast cancer have produced an increased number of breast cancer survivors. The type of sequelae and comorbidities that these patients present call for a collaborative follow-up by hospital-based specialized care and primary care. In this document, we present a guideline drafted and agreed among scientific societies whose members care for breast cancer survivors. The purpose of this guideline is to achieve the shared and coordinated follow-up of these patients by specialized care and primary care professionals. In it, we review the health issues derived from the treatments performed, with recommendations about the therapeutic approach to each of them, as well as a proposal for joint follow-up by primary and specialized care.
引用
收藏
页码:687 / 694
页数:7
相关论文
共 50 条
  • [1] Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC)
    Barnadas, A.
    Algara, M.
    Cordoba, O.
    Casas, A.
    Gonzalez, M.
    Marzo, M.
    Montero, A.
    Munoz, M.
    Ruiz, A.
    Santolaya, F.
    Fernandez, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 687 - 694
  • [2] Correction to: Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of Primary Care Physicians (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC)
    A. Barnadas
    M. Algara
    O. Cordoba
    A. Casas
    M. Gonzalez
    M. Marzo
    A. Montero
    M. Muñoz
    A. Ruiz
    F. Santolaya
    T. Fernandez
    Clinical and Translational Oncology, 2018, 20 : 803 - 804
  • [3] Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of Primary Care Physicians (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) (vol 20, pg 687, 2018)
    Barnadas, A.
    Algara, M.
    Cordoba, O.
    Casas, A.
    Gonzalez, M.
    Marzo, M.
    Montero, A.
    Munoz, M.
    Ruiz, A.
    Santolaya, F.
    Fernandez, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 803 - 804
  • [4] Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology
    Colomer, R.
    Aranda-Lopez, I.
    Albanell, J.
    Garcia-Caballero, T.
    Ciruelos, E.
    Lopez-Garcia, M. A.
    Cortes, J.
    Rojo, F.
    Martin, M.
    Palacios-Calvo, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (07): : 815 - 826
  • [5] Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology
    R. Colomer
    I. Aranda-López
    J. Albanell
    T. García-Caballero
    E. Ciruelos
    M. Á. López-García
    J. Cortés
    F. Rojo
    M. Martín
    J. Palacios-Calvo
    Clinical and Translational Oncology, 2018, 20 : 815 - 826
  • [6] Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology
    R. Colomer
    I. Aranda-López
    J. Albanell
    T. García-Caballero
    E. Ciruelos
    M. Á. López-García
    J. Cortés
    F. Rojo
    M. Martín
    J. Palacios-Calvo
    Clinical and Translational Oncology, 2018, 20 : 1093 - 1095
  • [7] Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
    Jose Otero, Maria
    Vera, Ruth
    Gonzalez-Perez, Cristina
    Ayala de la Pena, Francisco
    Penuelas, Angeles
    Quer, Nuria
    Manuel Sepulveda, Juan
    Domenech-Climent, Nuria
    Antonio Virizuela, Juan
    Beorlegui, Patricia
    Queralt Gorgas, Maria
    FARMACIA HOSPITALARIA, 2018, 42 (06) : 261 - 268
  • [8] Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
    Vera, R.
    Otero, M. J.
    Ayala de la Pena, F.
    Gonzalez-Perez, C.
    Penuelas, A.
    Sepulveda, J. M.
    Quer, N.
    Domenech-Climent, N.
    Virizuela, J. A.
    Beorlegui, P.
    Gorgas, M. Q.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (04): : 467 - 478
  • [9] Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
    Remon, J.
    Garcia-Campelo, R.
    de alava, E.
    Vera, R.
    Rodriguez-Peralto, J. L.
    Rodriguez-Lescure, A.
    Bellosillo, B.
    Garrido, P.
    Rojo, F.
    Alvarez-Alegret, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (06): : 823 - 834
  • [10] Executive Summary of the Spanish Guidelines for the Diagnosis and Management of Imported Febrile Illnesses from the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Imported Pathology Group of the Spanish Society of Infectious Diseases and Clinical Microbiology (GEPI-SEIMC), the Spanish Society of Family and Community Medicine (SEMFYC), the Spanish Society of Primary Care Physicians (SEMERGEN) and the Spanish Society of Emergency Medicine (SEMES)
    Camprubi-Ferrer, Daniel
    Menendez, Marta Diaz
    Crespillo-Andujar, Clara
    Galparsoro, Harkaitz Azkune
    Belhassen-Garcia, Moncef
    Gonzalez, Juan Cuadros
    Rubio, Jose M.
    Garcia, Jara Llenas
    Oteo, Jose A.
    Martin, Sara Gayoso
    Larregola, Laura Santos
    Salvador, Fernando
    Rojo-Marcos, Gerardo
    Balerdi-Sarasola, Leire
    Urkola, Xabier Kortajarena
    Perez, Manuel Jesus Soriano
    Onieva-Garcia, Maria angeles
    Coll, Inaki Alegria
    Arranz, Javier
    de Novales, Javier Membrillo
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2024, 42 (07): : 380 - 385